An RNA therapeutic strategy could have the potential to treat a wide range of genetic diseases caused by nonsense mutations.

Findings suggest that SARS-CoV-2 infection can activate an immune program that closely resembles those involved in ...

Salk researchers developed a genetic toolkit to isolate octopamine/tyramine neuron types in the Drosophila brain and link ...

Aprea Therapeutics is accelerating enrollment in its ongoing Phase I trial of its targeted cancer therapy APR-1051, one of ...

Life sciences industry group MassBio finds that growth-stage companies based in the Bay State are reaping the fruits of ...

Study may help to illuminate mechanisms that underlie sex differences in allergic diseases, and could help inform future ...

Moderna and Merck & Co. saw their stocks surge after announcing what they said were the first-ever positive Phase III results ...

Beyond the potential clinical application, the study sheds new light on T cell biology and how cells are directed towards specific lineages.

Pharma generates a huge amount of data in product development, but an untapped potential exists to use that information more ...

Researchers next plan to examine how other types of pesticides, as well as microplastics and other toxins, may contribute to ...

Lilly Gateway Labs is an innovation hub designed to help biotechnology companies advance groundbreaking science.

Researchers say understanding the evolution of antimicrobial peptides could help to inspire the development of better antibiotics.